Precision medicine approaches needed in oncology to match evolving SoC
Targeted patient recruitment can increase the likelihood of trial success and help cultivate use of precision medicine.
Therapy Area
Gilead’s HIV ART combo deemed non-inferior in second Phase III trial
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
Lilly’s triple G agonist boasts 28.7% weight loss in Phase III trial
ASH 2025: J&J’s Tecvayli + Darzalex set to redefine early relapsed MM
GRI Bio’s tazarotene achieves Phase IIa IPF success
Roche posts second Phase III win for oral SERD
New HBV vaccine guidance likely to increase infection among newborns
